BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients. [electronic resource]
Producer: 20111121Description: 3419-25 p. digitalISSN:- 1528-0020
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bendamustine Hydrochloride
- Cytarabine -- administration & dosage
- Drug Resistance, Neoplasm
- Etoposide -- administration & dosage
- Female
- Follow-Up Studies
- Graft Survival
- Hematopoietic Stem Cell Transplantation
- Hodgkin Disease -- immunology
- Humans
- Lymphoma, Non-Hodgkin -- immunology
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Nitrogen Mustard Compounds -- administration & dosage
- Recurrence
- Remission Induction
- Salvage Therapy -- methods
- Transplantation Conditioning -- methods
- Transplantation, Autologous
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.